Abstract
Numerous mammalian species have adapted to the chronic hypoxia of high altitude. Recent genomic studies have identified evidence for natural selection of genes and associated genetic changes in these species. A major gap in our knowledge is an understanding of the functional significance, if any, of these changes. Deer mice (Peromyscus maniculatus) live at both low and high altitudes in North America, providing an opportunity to identify functionally important genetic changes. High-altitude deer mice show evidence of natural selection on the Epas1 gene, which encodes for hypoxia-inducible factor-2α (Hif-2α), a central transcription factor of the hypoxia-inducible factor pathway. An SNP encoding for a T755M change in the Hif-2α protein is highly enriched in high-altitude deer mice, but its functional significance is unknown. Here, using coimmunoprecipitation and transcriptional activity assays, we show that the T755M mutation produces a defect in the interaction of Hif-2α with the transcriptional coactivator CREB-binding protein. This results in a loss of function because of decreased transcriptional activity. Intriguingly, the effect of this mutation depends on the amino acid context. Interchanges between methionine and threonine at the corresponding position in house mouse (Mus musculus) Hif-2α are without effects on CREB-binding protein binding. Furthermore, transfer of a set of deer mouse–specific Hif-2α amino acids to house mouse Hif-2α is sufficient to confer sensitivity of house mouse Hif-2α to the T755M substitution. These findings provide insight into high-altitude adaptation in deer mice and evolution at the Epas1 locus.
Keywords: evolution, factor inhibiting HIF, FIH, HIF, high-altitude adaptation, hypoxia, hypoxia-inducible factor, hydroxylase, transcription factor
Abbreviations: CBP, CREB-binding protein; CTAD, C-terminal transactivation domain; FIH, factor inhibiting HIF; HIF, hypoxia-inducible factor; HIF-α, α subunit of the transcription factor HIF; ODD, oxygen-dependent degradation; PHD2, prolyl hydroxylase domain protein 2; VHL, von Hippel Lindau
The chronic hypoxia of high altitude presents a substantial challenge to metazoans residing in this environment. Recent studies have revealed evidence of genetic adaptation to high altitude in multiple mammalian species. These include humans who reside on the Tibetan plateau, the Andean Altiplano, and Ethiopian Simien Mountains (1), as well as Tibetan dogs, yaks, sheep, and horses (2, 3).
In many of these species, there is evidence for natural selection acting on genes of the hypoxia-inducible factor (HIF) pathway, the main transcriptional pathway by which cells respond to hypoxia (4, 5, 6). The HIF pathway relies on two oxygen-dependent enzymes that act on the α subunit of the transcription factor HIF (HIF-α). One is prolyl hydroxylase domain protein 2 (PHD2), which catalyzes prolyl hydroxylation in the oxygen-dependent degradation (ODD) domain of HIF-α (7, 8, 9). Prolyl hydroxylated HIF-α (of which there are two main paralogues, HIF-1α and HIF-2α) is recognized by the von Hippel Lindau (VHL) protein, which then targets HIF-α for degradation. Under hypoxia, prolyl hydroxylation is arrested, leading to the stabilization of HIF-α. HIF-α dimerizes with aryl hydrocarbon receptor nuclear translocator through their basic Helix Loop Helix-Period Arnt Sim domains to form a transcription factor complex.
The other critical oxygen-dependent enzyme in this pathway is factor inhibiting HIF (FIH), which catalyzes asparaginyl hydroxylation in the C-terminal transactivation domain (CTAD) of HIF-α (10, 11, 12). This hydroxylation blocks the interaction of the CTAD with CREB-binding protein (CBP), a transcriptional coactivator with lysine acetyltransferase activity. CBP is a component of the transcription preinitiation complex, and it acetylates lysines 27 and 18 on histone H3, marks characteristic of active chromatin (13). Under hypoxia, asparaginyl hydroxylation is arrested, leading to the binding of HIF-α to CBP and activation of the CTAD.
HIF activates hundreds of genes involved in cellular and systemic responses to hypoxia (14). HIF-1α, which is ubiquitously expressed, upregulates the genes of glycolysis and thereby promotes a shift from oxidative phosphorylation to anaerobic glycolysis. HIF-2α, with a more restricted expression that is tissue and cell type specific, plays a critical role in other aspects of the hypoxic response (15, 16, 17, 18).
North American deer mice (Peromyscus maniculatus) reside at both low and high altitudes, providing an opportunity to examine genes that might facilitate hypoxic adaption (19). One mechanism by which this occurs is through amino acid substitutions in the α and β chains of hemoglobin that increase binding affinity for oxygen (20). It has recently been reported that the Epas1 gene, which encodes for Hif-2α, is under natural selection in high-altitude deer mice (21). The Epas1 gene is the target of selection in multiple high-altitude species (2, 3). However, there is a dearth of knowledge regarding mechanisms by which high-altitude Epas1 alleles might be adaptive. In deer mice, the high-altitude allele is correlated with decreased expression of adrenal catecholamine synthesis genes and an increased heart rate under hypoxic conditions. The highest ranking SNP in the Epas1 gene resides in exon 14 and encodes for a T755M polymorphism. This SNP is not present in deer mice at sea level, and it rises to a frequency of >0.8 in deer mouse populations at high altitude (21). In the primary sequence, amino acid 755 resides between and is distant from the ODD domain and CTAD. Therefore, it is not intuitively obvious whether the polymorphism has any functional significance. There are no other Epas1 SNPs under selection that produce a change in the amino acid sequence.
Here we provide evidence that high-altitude deer mouse Hif-2α is a loss of function allele that produces a defect in the interaction of Hif-2α with Cbp. This provides a framework for understanding high-altitude adaptation in deer mice and shows a naturally occurring mutation in a mammalian Epas1 gene that affects the function of the CTAD of Hif-2α. More broadly, it provides important information for understanding convergent evolution at the Epas1 locus in mammalian high-altitude species.
Results and discussion
To test whether the T755M mutation affects protein stability, we transfected HEK293FT cells with constructs for WT and T755M deer mouse Hif-2α, exposed some cells to hypoxia (0.5% O2), and then examined protein levels by Western blotting. We did not observe any significant difference in protein levels between WT and T755M deer mouse Hif-2α under either normoxia or hypoxia (Fig. 1A, lanes 2 and 3, and lanes 5 and 6).
The ODD domain of Hif-2α interacts with two proteins—Phd2 when not hydroxylated, and Vhl when hydroxylated. We examined these interactions. We were not able to detect binding between Hif-2α and Phd2 under hypoxia (data not shown). As an alternative, we used dimethyloxalylglycine, an active site inhibitor of 2-oxoglutarate dependent enzymes (which includes Phd2), that allows for the formation of enzyme:substrate complexes (22). We transfected cells with WT or T755M deer mouse Hif-2α constructs along with one for Phd2, exposed cells to dimethyloxalylglycine, and examined Phd2 immunoprecipitates for Hif-2α. We do not see any appreciable differences in the interaction of Phd2 with WT and T755M deer mouse Hif-2α (Fig. 1, B and C). To examine the binding of Vhl with hydroxylated Hif-2α, we transfected cells with the Hif-2α constructs along with one encoding for deer mouse Vhl. We treated cells with the proteasome inhibitor MG-132 to stabilize the prolyl hydroxylated from of Hif-2α. We observe no significant differences in the amount of WT and T755M Hif-2α recovered in Vhl immunoprecipitates (Fig. 1, D and E).
The CTAD (residues 834–874) of Hif-2α can bind Fih. We fused WT or T755M deer mouse Hif-2α (669–874), which contains the CTAD, to the DNA-binding domain of the GAL4 protein. We transfected cells with these constructs along with one for deer mouse Fih and exposed cells to hypoxia (0.5% O2) to stabilize the nonhydroxylated form of Hif-2α. Hif-2α (669–874) is detectable in Fih immunoprecipitates, and we do not see a difference in the interaction with Fih between WT and T755M deer mouse Hif-2α (669–874) (Fig. 1F, lanes 2 and 4).
In its nonhydroxylated form, the CTAD can interact with Cbp through the zinc finger–containing CH1 (also known as TAZ1) domain of the latter (23). We transfected cells with the Hif-2α (669–874) constructs along with one for the CH1 domain of deer mouse Cbp (residues 338–442, fused to GST). We exposed the cells to hypoxia (0.5% O2) to block hydroxylation and examined Cbp immunoprecipitates for Hif-2α. In contrast to the interactions with Phd2, Vhl, and Fih, the T755M mutation in Hif-2α dramatically impairs the interaction with Cbp (Fig. 2A). We observed the same result with full-length WT and T755M Hif-2α (Fig. 2B). Longer exposures of these Western blots reveal a weak Hif-2α band in the Cbp immunoprecipitates. Therefore, the mutation is hypomorphic, that is, it produces a partial but not complete loss of function.
Previous studies have shown that an Asn > Ala substitution at the site of Fih-catalyzed hydroxylation (Asn-851 in deer mouse Hif-2α) allows constitutive Cbp binding and CTAD activation under normoxia (12). Coimmunoprecipitation studies using Hif-2α (669–874) N851A show that this substitution (N851A) in Hif-2α allows CTAD:Cbp binding under normoxia in a manner sensitive to the T755M mutation (Fig. 2C, lanes 2 and 4). We assessed the interaction of these two Hif-2α (669–874) proteins with endogenous Cbp in a murine cellular environment by transfecting mouse N2a cells with the Hif-2α (669–874) constructs and then immunoprecipitating the Hif-2α. The T755M mutation impairs the interaction with endogenous Cbp in this experimental setting (Fig. 2D, lanes 2 and 3).
The protein p300 is a paralogue of Cbp with a homologous zinc finger that interacts with the CTAD (24). We examined the interaction of Hif-2α (669–874) N851A with the CH1 zinc finger domain of deer mouse p300 (residues 324–428). In contrast to Cbp, binding is maintained with the T755M mutation (Fig. 2E, lanes 2 and 4). Although we cannot exclude the possibility that there might be subtle effects on the binding of the T755M mutant to Phd2, Vhl, Fih, or p300, the results indicate that the T755M mutation in deer mouse Hif-2α primarily impairs interaction with Cbp.
To assess transcriptional activity, we transfected 293FT cells with constructs for full-length Hif-2α–bearing mutations at the prolyl (P529A) and asparaginyl (N851A) sites that lead to constitutive activity under normoxia (to allow assessment of Hif-2α activity in the absence of endogenous HIF), along with a luciferase reporter gene driven by three copies of hypoxia response element from the ERYTHROPOIETIN gene (25). In the context of the P529A/N851A substitutions, the T755M mutant of deer mouse Hif-2α has lower transcriptional activity than WT (Fig. 3A). We examined the transcriptional activity of the GAL4–Hif-2α (669–874) fusion protein (without the N581A mutation) under normoxia and hypoxia with the use of a luciferase reporter gene driven by GAL4 binding sites. Hypoxia induces higher reporter gene activity from the WT Hif-2α (669–874) fusion protein, and the T755M mutation confers lower activity under either normoxia or hypoxia (Fig. 3B). The activity of Hif-2α is only partially reduced in these reporter gene assays, consistent with the partial (as opposed to complete) loss of interaction with Cbp and the preservation of interaction with p300.
We assessed the effect of the T755M mutation on endogenous Hif-2α gene targets by generating HEK293 cells stably expressing WT and T755M deer mouse Hif-2α from an isogenic locus (using the Flp-In TRex system) (Fig. 3, C and D). These two constructs were in the P529A/N851A background to allow assessment under normoxia and avoid interference from endogenous HIF. Deer mouse Hif-2α induces transcriptional activation of the HIF-2α target genes VEGFA, NDRG1, ADM, and SLC7A5 (Fig. 3, E–H). Importantly, the T755M mutation diminishes activation of these genes.
The deer mouse mutation changes residue 755 to an amino acid, methionine, that is the native amino acid at residue 755 in house mouse (Mus musculus) Hif-2α (MmHif-2α). We examined the effect of the converse substitution, M755T, on the interaction between house mouse Hif-2α with house mouse Cbp (338–442), the sequence of which is identical to deer mouse Cbp (338–442). In contrast to deer mouse Hif-2α, we find that both WT (M755) and M755T house mouse Hif-2α (670–874) interact with Cbp (Fig. 3I, lanes 2 and 4). Therefore, the interchange between methionine and threonine at this position in house mouse Hif-2α lacks the same functional effect that is observed in deer mouse Hif-2α.
Besides amino acid 755, deer mouse Hif-2α (669–874) differs from house mouse Hif-2α (670–874) at 19 additional residues (Fig. 4A). This suggests that the loss of function effect of the T755M mutation in Hif-2α is only seen in the context of amino acid substitutions that are present in deer mouse Hif-2α (669–874). We prepared hybrid constructs in which specific regions of deer mouse Hif-2α (669–874) were inserted into the corresponding sequence of house mouse Hif-2α (residues 670–874) to determine which could confer sensitivity to the T755M mutation (Fig. 4A). We prepared five hybrid constructs, designated H1 to H5, that span the entire region of dissimilarity between deer mouse and house mouse Hif-2α and prepared T755 and M755 versions of each. The first two of these, H1 and H2, behave similarly to house mouse Hif-2α (670–874), that is, the T755M mutation preserves Cbp binding (Fig. 4B). In contrast, with H3, the T755M mutation impairs binding (Fig. 4C, lanes 4 and 5). In additional hybrids in which the deer mouse region of H3 was subdivided into two, producing H4 and H5 hybrids, we found that the T755M mutation maintains binding to Cbp in both cases, that is, the deleterious effect is lost (Fig. 4D). This suggests that multiple deer mouse amino acid substitutions in H3 (which includes T792A, R793V, S795P, T801S, C807G, G816S, Q821P, V826M) are necessary to confer sensitivity of Cbp binding in house mouse Hif-2α to the presence of methionine at residue 755.
Under normoxia, prolyl and asparaginyl hydroxylation inhibit Hif-2α (Fig. 5A), whereas under hypoxia, this inhibition is relieved (Fig. 5B, left). We find that the North American high-altitude deer mouse T755M mutation in Hif-2α produces a loss of function effect via impaired binding to Cbp (Fig. 5B, right). In vivo, the corresponding SNP in the Epas1 gene is associated with decreased levels of catecholamine biosynthetic gene expression in the adrenal gland (21). Because previous observations indicated that HIF-2α is required for catecholamine synthesis in sympathoadrenal cells (26), our results could provide a mechanistic explanation for this. The resulting vasodilation might lead to compensatory increased heart rate, which has been observed (21).
Residue 755 is in a region of deer mouse Hif-2α that resides between the ODD domain and CTAD (Fig. 4A) and is not as highly conserved as either the ODD domain or CTAD. We find that the differences in the behavior of Thr and Met at this position are context dependent and seen only in deer mouse, but not house mouse, Hif-2α. This depends on a region in deer mouse Hif-2α (residues 792–826) that includes multiple amino acid substitutions. This may represent an example of intramolecular epistasis (27), somewhat analogous to the intramolecular epistasis that has been observed in high-altitude deer mouse hemoglobin (28). We propose the following. Deer mouse and house mouse Hif-2α arose from a common ancestor (Fig. 5C). The ancestral M755 is indicated by “a”, whereas the other ancestral amino acids are indicated by “b”. Low-altitude deer mouse Hif-2α acquired amino acid substitutions that are indicated by “A” for M755T and “B” for the 19 other amino acid changes (Fig. 4A). The “AB” haplotype in deer mice is neutral under low-altitude conditions but is maladaptive at a high altitude. The “B” substitutions, however, provide a genetic background in which a reversion of “A” to the ancestral “a” allows the acquisition of a functional adaptive change in Hif-2α at high altitude (i.e., the “aB” haplotype). In a “b” background, interchange between “a” and “A” is otherwise neutral.
No three-dimensional structure is available for the region in Hif-2α in which Thr-755 resides, and it is conceivable that it might be a disordered region. If so, Thr-755 of Hif-2α may bear similarity to residue 127 in human PHD2, which is in a poorly conserved, possibly disordered, region of PHD2 located between a zinc finger and the catalytic domain of PHD2. Tibetans harbor a C127S substitution in PHD2 that, in the context of the WT protein, is without an appreciable effect in vitro. However, in the context of a D4E mutation that is adjacent to the PHD2 zinc finger, the C127S substitution results in markedly impaired interaction of PHD2 with the HSP90 cochaperone p23, leading to loss of function (29, 30). We propose that the high-altitude deer mouse T755M Hif-2α mutation and the human Tibetan C127S PHD2 substitution represent two independent adaptive amino acid changes in the HIF pathway that occur in potentially disordered regions of the respective proteins, produce loss of function in the context of other selective amino acid changes, and promote adaptation to the chronic hypoxia of high altitude.
Experimental procedures
Experimental procedures are available in Supporting information. Each experiment was performed at least two times. For some experiments, data were analyzed by two-tailed student’s t test (GraphPad Prism 7).
Data availability
All data relevant to these studies are contained within the article.
Supporting information
This article contains supporting information (25, 31, 32, 33, 34, 35, 36).
Conflict of interest
The authors declare that they have no conflicts of interest with the contents of this article.
Acknowledgments
Author contributions
D. S. and F. S. L. conceptualization; D. S. investigation; D. S., A. W. B., and F. S. L. formal analysis; D. S. and F. S. L. writing—original draft; A. W. B. writing—review and editing; F. S. L. and A. W. B. funding acquisition.
Funding and additional information
This work was supported by NIH Grants R01-DK104796 (to F. S. L.) and R33-HL120751 (to F. S. L. and A. W. B.) and a grant from the University of Pennsylvania Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Edited by Ursula Jakob
Supporting information
References
- 1.Bigham A.W., Lee F.S. Human high-altitude adaptation: Forward genetics meets the HIF pathway. Genes Dev. 2014;28:2189–2204. doi: 10.1101/gad.250167.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Witt K.E., Huerta-Sanchez E. Convergent evolution in human and domesticate adaptation to high-altitude environments. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2019;374:20180235. doi: 10.1098/rstb.2018.0235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Pamenter M.E., Hall J.E., Tanabe Y., Simonson T.S. Cross-species insights into genomic adaptations to hypoxia. Front. Genet. 2020;11:743. doi: 10.3389/fgene.2020.00743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kaelin W.G., Jr., Ratcliffe P.J. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol. Cell. 2008;30:393–402. doi: 10.1016/j.molcel.2008.04.009. [DOI] [PubMed] [Google Scholar]
- 5.Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399–408. doi: 10.1016/j.cell.2012.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell. 2010;40:294–309. doi: 10.1016/j.molcel.2010.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Huang L.E., Gu J., Schau M., Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2- dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U. S. A. 1998;95:7987–7992. doi: 10.1073/pnas.95.14.7987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43–54. doi: 10.1016/s0092-8674(01)00507-4. [DOI] [PubMed] [Google Scholar]
- 9.Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337–1340. doi: 10.1126/science.1066373. [DOI] [PubMed] [Google Scholar]
- 10.Cockman M.E., Webb J.D., Ratcliffe P.J. FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Ann. N. Y. Acad. Sci. 2009;1177:9–18. doi: 10.1111/j.1749-6632.2009.05042.x. [DOI] [PubMed] [Google Scholar]
- 11.Strowitzki M.J., Cummins E.P., Taylor C.T. Protein hydroxylation by hypoxia-inducible factor (HIF) hydroxylases: Unique or ubiquitous? Cells. 2019;8:384. doi: 10.3390/cells8050384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002;295:858–861. doi: 10.1126/science.1068592. [DOI] [PubMed] [Google Scholar]
- 13.Attar N., Kurdistani S.K. Exploitation of EP300 and CREBBP lysine acetyltransferases by Cancer. Cold Spring Harb. Perspect. Med. 2017;7 doi: 10.1101/cshperspect.a026534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Schodel J., Mole D.R., Ratcliffe P.J. Pan-genomic binding of hypoxia-inducible transcription factors. Biol. Chem. 2013;394:507–517. doi: 10.1515/hsz-2012-0351. [DOI] [PubMed] [Google Scholar]
- 15.Lappin T.R., Lee F.S. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis. Blood Rev. 2019;37:100590. doi: 10.1016/j.blre.2019.100590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wenger R.H., Hoogewijs D. Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells. Am. J. Physiol. Renal Physiol. 2010;298:F1287–F1296. doi: 10.1152/ajprenal.00736.2009. [DOI] [PubMed] [Google Scholar]
- 17.Keith B., Johnson R.S., Simon M.C. HIF1alpha and HIF2alpha: Sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer. 2012;12:9–22. doi: 10.1038/nrc3183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tan Q., Kerestes H., Percy M.J., Pietrofesa R., Chen L., Khurana T.S., Christofidou-Solomidou M., Lappin T.R., Lee F.S. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation. J. Biol. Chem. 2013;288:17134–17144. doi: 10.1074/jbc.M112.444059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Storz J.F., Cheviron Z.A., McClelland G.B., Scott G.R. Evolution of physiological performance capacities and environmental adaptation: Insights from high-elevation deer mice (Peromyscus maniculatus) J. Mammal. 2019;100:910–922. doi: 10.1093/jmammal/gyy173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Storz J.F., Moriyama H. Mechanisms of hemoglobin adaptation to high altitude hypoxia. High Alt. Med. Biol. 2008;9:148–157. doi: 10.1089/ham.2007.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Schweizer R.M., Velotta J.P., Ivy C.M., Jones M.R., Muir S.M., Bradburd G.S., Storz J.F., Scott G.R., Cheviron Z.A. Physiological and genomic evidence that selection on the transcription factor Epas1 has altered cardiovascular function in high-altitude deer mice. PLoS Genet. 2019;15 doi: 10.1371/journal.pgen.1008420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cockman M.E., Webb J.D., Kramer H.B., Kessler B.M., Ratcliffe P.J. Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Mol. Cell. Proteomics. 2009;8:535–546. doi: 10.1074/mcp.M800340-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dames S.A., Martinez-Yamout M., De Guzman R.N., Dyson H.J., Wright P.E. Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. U. S. A. 2002;99:5271–5276. doi: 10.1073/pnas.082121399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Freedman S.J., Sun Z.Y., Poy F., Kung A.L., Livingston D.M., Wagner G., Eck M.J. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. U. S. A. 2002;99:5367–5372. doi: 10.1073/pnas.082117899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yu F., White S.B., Zhao Q., Lee F.S. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein. Cancer Res. 2001;61:4136–4142. [PubMed] [Google Scholar]
- 26.Brown S.T., Kelly K.F., Daniel J.M., Nurse C.A. Hypoxia inducible factor (HIF)-2 alpha is required for the development of the catecholaminergic phenotype of sympathoadrenal cells. J. Neurochem. 2009;110:622–630. doi: 10.1111/j.1471-4159.2009.06153.x. [DOI] [PubMed] [Google Scholar]
- 27.Storz J.F. Compensatory mutations and epistasis for protein function. Curr. Opin. Struct. Biol. 2018;50:18–25. doi: 10.1016/j.sbi.2017.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Natarajan C., Inoguchi N., Weber R.E., Fago A., Moriyama H., Storz J.F. Epistasis among adaptive mutations in deer mouse hemoglobin. Science. 2013;340:1324–1327. doi: 10.1126/science.1236862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Song D., Li L.S., Arsenault P.R., Tan Q., Bigham A.W., Heaton-Johnson K.J., Master S.R., Lee F.S. Defective Tibetan PHD2 binding to p23 links high altitude adaptation to altered oxygen sensing. J. Biol. Chem. 2014;289:14656–14665. doi: 10.1074/jbc.M113.541227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Song D., Navalsky B.E., Guan W., Ingersoll C., Wang T., Loro E., Eeles L., Matchett K.B., Percy M.J., Walsby-Tickle J., McCullagh J.S.O., Medina R.J., Khurana T.S., Bigham A.W., Lappin T.R. Tibetan PHD2, an allele with loss-of-function properties. Proc. Natl. Acad. Sci. U. S. A. 2020;117:12230–12238. doi: 10.1073/pnas.1920546117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zhao Q., Lee F.S. The transcriptional activity of the APP intracellular domain-Fe65 complex is inhibited by activation of the NF-kappaB pathway. Biochemistry. 2003;42:3627–3634. doi: 10.1021/bi027117f. [DOI] [PubMed] [Google Scholar]
- 32.Song D., Li L.S., Heaton-Johnson K.J., Arsenault P.R., Master S.R., Lee F.S. Prolyl hydroxylase domain protein 2 (PHD2) binds a Pro-Xaa-Leu-Glu motif, linking it to the heat shock protein 90 pathway. J. Biol. Chem. 2013;288:9662–9674. doi: 10.1074/jbc.M112.440552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Arsenault P.R., Pei F., Lee R., Kerestes H., Percy M.J., Keith B., Simon M.C., Lappin T.R., Khurana T.S., Lee F.S. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism. J. Biol. Chem. 2013;288:33571–33584. doi: 10.1074/jbc.M113.482364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 2003;23:9361–9374. doi: 10.1128/MCB.23.24.9361-9374.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Furlow P.W., Percy M.J., Sutherland S., Bierl C., McMullin M.F., Master S.R., Lappin T.R., Lee F.S. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline. J. Biol. Chem. 2009;284:9050–9058. doi: 10.1074/jbc.M808737200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Bouthelier A., Melendez-Rodriguez F., Urrutia A.A., Aragones J. Differential contribution of N- and C-terminal regions of HIF1alpha and HIF2alpha to their target gene selectivity. Int. J. Mol. Sci. 2020;21:9401. doi: 10.3390/ijms21249401. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data relevant to these studies are contained within the article.